Hyperbilirubinemia in pazopanib- or sunitinib-treated patients in COMPARZ is associated with UGT1A1 polymorphisms
Journal article published in 2013 by
R. J. Motzer,
T. Johnson 
,
T. K. Choueiri,
K. C. Deen,
Z. Xue,
L. N. Pandite,
C. Carpenter,
C. F. Xu
,
T. K. Choueiri,
K. C. Deen,
Z. Xue,
L. N. Pandite,
C. Carpenter,
C. F. Xu
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 